US stocks on the move: Salesforce, Brown & Brown, IonQ, Harmony Biosciences
CRM•Salesforce was upgraded to “buy” by BofA, while TD Cowen started Brown & Brown at “buy.” IonQ shares fell after its $1.3 billion acquisition of cybersecurity company Elisity, and Harmony Biosciences shares fell as CEO Dayno prepares to retire and its COO takes over.
1. Analyst ratings
BofA double-upgraded Salesforce to “buy.” TD Cowen began coverage of Brown & Brown with a “buy” rating.
2. Company developments
IonQ shares fell after its $1.3 billion acquisition of cybersecurity company Elisity. Harmony Biosciences shares fell after it said CEO Dayno would retire and its COO would take over.
